This blog highlights research and development of new treatments, outcomes of global clinical trials and their regulations, with a special focus on ophthalmology and retinal diseases, including drugs and devices. The blog is meant for both clinical and pharmaceutical experts, as well as for patients / family members who are looking for information.
The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.
